Medicare Enrolled
Dr. Joseph Mace, MD
Hematology · St Petersburg, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Mace from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mace? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Mace
Dr. Joseph Mace is a hematology in St Petersburg, FL, with 20 years in practice. Based on federal Medicare data, Dr. Mace performed 151,910 Medicare services across 2,208 unique beneficiaries.
Between the years covered by Open Payments, Dr. Mace received a total of $19,815 from 85 pharmaceutical and/or device companies across 553 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mace is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 36% volume in FL$ $19,815 industry payments
Medicare Practice Summary
Medicare Utilization ↗151,910
Medicare services
Top 36% in FL for hematology
2,208
Unique beneficiaries
$2
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~7,596 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Filgrastim injection (Zarxio) for white blood cells | 50,760 | $0 | $2 |
| Filgrastim injection (Nivestym) for white blood cells | 36,900 | $0 | $1 |
| Iron sucrose injection (Venofer) | 23,700 | $0 | $5 |
| Iron infusion (Feraheme) | 10,200 | $0 | $4 |
| Anti-nausea injection (aprepitant) | 10,010 | $1 | $5 |
| Denosumab injection (Prolia/Xgeva) | 5,220 | $18 | $51 |
| Epoetin alfa injection (Procrit) for anemia | 2,950 | $6 | $23 |
| Dexamethasone injection (steroid) | 2,265 | $0 | $3 |
| Complete blood count (CBC) with differential | 1,584 | $8 | $29 |
| Blood draw (venipuncture) | 1,421 | $8 | $9 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,370 | $1 | $28 |
| Drug injection, under skin or into muscle | 713 | $10 | $69 |
| Office visit, established patient (30-39 min) | 476 | $95 | $339 |
| Anti-nausea injection (ondansetron/Zofran) | 464 | $0 | $9 |
| Injection, magnesium sulfate, per 500 mg | 436 | $1 | $2 |
| Office visit, established patient (20-29 min) | 408 | $65 | $239 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 394 | $22 | $84 |
| Injection, carboplatin, 50 mg | 334 | $2 | $41 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 321 | $48 | $189 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 306 | $1 | $6 |
| Administration of chemotherapy into vein, 1 hour or less | 249 | $98 | $378 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 237 | $15 | $56 |
| Injection of additional new drug or substance into vein | 198 | $12 | $61 |
| Injection, diphenhydramine hcl, up to 50 mg | 140 | $1 | $3 |
| Office visit, established patient, complex (40-54 min) | 108 | $136 | $474 |
| Infusion into a vein for hydration, each additional hour | 98 | $10 | $42 |
| Administration of chemotherapy into vein, each additional hour | 86 | $22 | $79 |
| Injection, zoledronic acid, 1 mg | 86 | $6 | $69 |
| Infusion, normal saline solution , 1000 cc | 84 | $2 | $7 |
| Administration of additional new drug or substance into vein, 1 hour or less | 80 | $49 | $178 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 69 | $16 | $59 |
| Infusion into a vein for hydration, 31-60 minutes | 61 | $25 | $156 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 42 | $25 | $89 |
| Initial hospital admission, high complexity | 30 | $131 | $556 |
| Hospital follow-up visit, high complexity | 30 | $94 | $285 |
| Automated urinalysis | 27 | $2 | $8 |
| New patient office visit, complex (60-74 min) | 24 | $144 | $585 |
| Red blood count, automated test | 15 | $4 | $10 |
| Injection of drug or substance into vein | 14 | $28 | $156 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
7.5% high complexity
89.7% medium
2.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$19,815
Total received (2018-2024)
Avg $2,831/year across 7 years
Top 24% in FL for hematology
85
Companies
553
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,966 (50.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$8,765 (44.2%)
Other
Charitable contributions, space rental, and other categories
$819 (4.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$265 (1.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$2,891
2023$2,715
2022$1,838
2021$56
2020$352
2019$9,469
2018$2,494
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Spectrum Pharmaceuticals Inc.
$7,889
Novartis Pharmaceuticals Corporation
$1,471
Bayer HealthCare Pharmaceuticals Inc.
$949
E.R. Squibb & Sons, L.L.C.
$724
PFIZER INC.
$632
Daiichi Sankyo Inc.
$556
Janssen Biotech, Inc.
$488
Lilly USA, LLC
$469
Gilead Sciences, Inc.
$404
Celgene Corporation
$388
GENZYME CORPORATION
$376
AstraZeneca Pharmaceuticals LP
$339
NOVARTIS PHARMACEUTICALS CORPORATION
$299
Amgen Inc.
$299
Takeda Pharmaceuticals U.S.A., Inc.
$295
Astellas Pharma US Inc
$234
GlaxoSmithKline, LLC.
$220
Genentech USA, Inc.
$183
Seagen Inc.
$182
Incyte Corporation
$168
Exelixis Inc.
$153
Stemline Therapeutics Inc.
$151
Merck Sharp & Dohme Corporation
$148
EMD Serono, Inc.
$146
Blueprint Medicines Corporation
$111
SANOFI-AVENTIS U.S. LLC
$99
PharmaEssentia USA Corporation
$98
SOBI, INC
$95
ABBVIE INC.
$94
Eisai Inc.
$93
Merck Sharp & Dohme LLC
$89
ARRAY BIOPHARMA INC
$81
TAIHO ONCOLOGY, INC.
$80
Kite Pharma, Inc.
$78
Janssen Pharmaceuticals, Inc
$78
Fennec Pharmaceuticals, Inc.
$73
Seattle Genetics, Inc.
$72
Ipsen Biopharmaceuticals, Inc
$70
Puma Biotechnology, Inc.
$59
Pharmacosmos Therapeutics Inc.
$59
EISAI INC.
$58
Sumitomo Pharma America, Inc.
$56
Karyopharm Therapeutics Inc.
$54
Taiho Oncology, Inc.
$53
CSL Behring
$52
AbbVie, Inc.
$48
Novocure Inc.
$45
Acrotech Biopharma Inc.
$44
Foundation Medicine, Inc.
$43
Sysmex Inostics Inc
$41
Array BioPharma Inc.
$40
Novo Nordisk Inc
$37
Bayer Healthcare Pharmaceuticals Inc.
$37
Global Blood Therapeutics, Inc.
$36
JAZZ PHARMACEUTICALS INC.
$35
Dendreon Pharmaceuticals LLC
$35
PUMA BIOTECHNOLOGY, INC.
$34
Rigel Pharmaceuticals, Inc.
$34
TerSera Therapeutics LLC
$34
SpringWorks Therapeutics, Inc.
$32
Regeneron Healthcare Solutions, Inc.
$28
Alexion Pharmaceuticals, Inc.
$27
Kyowa Kirin, Inc.
$26
Aurobindo Pharma USA, Inc.
$26
Lexicon Pharmaceuticals, Inc.
$26
Pharmacyclics LLC, an AbbVie Company
$24
Aveo Pharmaceuticals, Inc.
$22
MorphoSys, US Inc.
$20
CTI BioPharma Corp.
$20
AbbVie Inc.
$20
Pharmacyclics LLC, An AbbVie Company
$19
Allergan Inc.
$19
AMAG Pharmaceuticals, Inc.
$18
Myriad Genetic Laboratories, Inc.
$18
GE HealthCare
$17
Organon LLC
$17
SHIELD THERAPEUTICS INC
$17
BeiGene USA, Inc.
$17
Myovant Sciences Inc.
$16
AVEO Pharmaceuticals, Inc.
$16
Alnylam Pharmaceuticals Inc.
$14
Dova Pharmaceuticals
$14
Sysmex America, Inc.
$12
Clovis Oncology, Inc.
$12
EUSA Pharma (US) LLC
$11
Top 3 companies account for 52.0% of total payments
Associated products mentioned in payments ›
ACCRUFER · ADAKVEO · ADCETRIS · ALUNBRIG · AUGTYRO · AYVAKIT · Abraxane · Afstyla · Alecensa · Aliqopa · Avastin · BAVENCIO · BELEODAQ · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Balversa · Bavencio · Braftovi · CABOMETYX · CALQUENCE · CERDELGA · CYRAMZA · Cabometyx · Creon · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ELITEK · ELREXFIO · EMEND · ENHERTU · ERLEADA · EVENITY · EXKIVITY · Enhertu · Erleada · FARESTON · FASLODEX · FERAHEME · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Folotyn · GAZYVA · GIVLAARI · HEMGENIX · IBRANCE · IMBRUVICA · IMFINZI · INLYTA · Idelvion · Itovebi · JADENU · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MONOFERRIC · MYRISK · NERLYNX · NINLARO · Nerlynx · Nexavar · Nplate · Nubeqa · OGSIVEO · OJJAARA · ONTRUZANT · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Oncology · Onivyde · Orserdu · PADCEV · PIQRAY · PLUVICTO · PROMACTA · PROVENGE · Padcev · Pedmark · Perjeta · Pomalyst · Poteligeo · REBLOZYL · RYBREVANT · Rebinyn · Revlimid · Rezlidhia · Rubraca · SANDOSTATIN · SARCLISA · SHINGRIX · SOMATULINE DEPOT · SUTENT · Somatuline Depot · Sylvant · TABRECTA · TASIGNA · TECVAYLI · TUKYSA · Trodelvy · ULTOMIRIS · VARUBI · VENCLEXTA · VERZENIO · VOTRIENT · Venclexta · Vonjo · XALKORI · XARELTO · XN Series · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · Yescarta · ZENPEP · ZEPZELCA · ZOLADEX · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (50%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $13 per 100 Medicare services performed
Geographic Context
Hematologys within 10 mi
42
Per 100K population
4.4
County median income
$70,293
Nearest hospital
ORLANDO HEALTH BAYFRONT HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Mace is a mixed practice specialist, with moderate Medicare volume, and low-engagement industry engagement, with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Mace experienced with filgrastim injection (zarxio) for white blood cells?
Based on Medicare claims data, Dr. Mace performed 50,760 filgrastim injection (zarxio) for white blood cells services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mace receive payments from pharmaceutical companies?
Yes. Dr. Mace received a total of $19,815 from 85 companies across 553 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mace's costs compare to other hematologys in St Petersburg?
Dr. Mace's average Medicare payment per service is $2. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mace) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologys in St Petersburg
Browse hematologys in St Petersburg ranked by procedure volume and transparency data.
Highest volume
Top Hematologys in FL
Hematologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologys in FL
Which FL hematologys receive the most from drug and device companies.
By company
Spectrum Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Spectrum Pharmaceuticals Inc..
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Bayer HealthCare Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Bayer HealthCare Pharmaceuticals Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology